seed
Stage
2
Investors
About
Biointaxis is an academic biotech spin-off developing gene therapy treatments targeting rare genetic neurodegenerative diseases, primarily Friedreich's ataxia, and aims to license its products to pharmaceutical partners after early clinical development.
Explore Biointaxis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.